Adaptive Biotechnologies Corp. (ADPT)
15.76
+0.90
(+6.06%)
USD |
NASDAQ |
Dec 10, 16:00
15.43
-0.33
(-2.09%)
After-Hours: 16:55
Adaptive Biotechnologies Total Assets (Quarterly): 490.61M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Akero Therapeutics, Inc. | 1.006B |
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Vertex Pharmaceuticals, Inc. | 24.86B |
| Ultragenyx Pharmaceutical, Inc. | 1.190B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 286.36M |
| Shareholders Equity (Quarterly) | 204.44M |
| Debt to Equity Ratio | 1.045 |
| Current Ratio | 3.376 |
| Net Debt Paydown Yield | 0.11% |